Navigation Links
Amarin's AMR101 Phase 3 ANCHOR Trial Meets all Primary and Secondary Endpoints with Statistically Significant Reductions in Triglycerides at Both 4 Gram and 2 Gram Doses and Statistically Significant Decrease in LDL-C
Date:4/17/2011

y to evaluate the efficacy and safety of 2 grams and 4 grams of AMR101, enrolled 702 patients with fasting triglyceride levels from 200 mg/dL to less than 500 mg/dL who were also on background statin therapy (treated to the National Cholesterol Education Program Adult Treatment Panel III (NCEP III) target goal of 100 mg/dL). Patients in this trial were characterized as having high triglyceride levels according to the NCEP III treatment guidelines.  The secondary endpoints in the ANCHOR trial include the difference in LDL-cholesterol levels between AMR101-treated and placebo-treated groups to demonstrate that the addition of AMR101 to statin therapy does not increase LDL-cholesterol (LDL-C or "bad cholesterol") in this population. Both treatment groups received statin therapy for the treatment of high LDL-cholesterol. Secondary measures in the ANCHOR trial were the difference in other lipid and biomarker levels between AMR101 and placebo treatment groups.  

The three background statins used in the ANCHOR trial, simvastatin, atorvastatin or rosuvastatin, represent approximately 80% of statins currently used.  The most common trade names for these drugs are Zocor®, Lipitor® and Crestor®, respectively.

About AMR101

AMR101 is a prescription-grade omega-3 fatty acid, comprising not less than 96% ultra pure icosapent ethyl (ethyl-EPA), that Amarin is developing as a potentially best-in-class prescription medicine for the treatment of patients with very high triglyceride levels (>500 mg/dL) and as a potentially first-in-class therapy for patients with high triglyceride levels (>200 and <500mg/dL) who are also on statin therapy for elevated LDL-cholesterol levels. Significant scientific and clinical evidence support the efficacy and safety of ethyl-EPA in reducing triglyceride levels.

About Amarin

Amarin Corporation plc is a clinical-stage biopharmaceutical company with expertise
'/>"/>

SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 1, 2015  Thoratec Corporation (NASDAQ: THOR ), a ... and restore failing hearts, announced today that Marta Antonucci ... President, International. This new Europe ... of North America , including ... Latin America , and reports directly to the ...
(Date:5/1/2015)...  Legendary actor and director Danny Glover ... designed to educate and encourage patients with neurologic conditions, ... (PBA) and to speak with their physician. The campaign ... ability to cry and laugh on cue and how ... people living with PBA episodes. While PBA ...
(Date:5/1/2015)... , May 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... Timothy E. Morris , chief financial officer  will be ... events are as follows: Mizuho Third Annual ...  The Omni Berkshire Place, New York ...
Breaking Medicine Technology:Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2
... May 10, 2011 Cobalis Corp. (CLSC.PK) announced today ... PreHistin® Allergy Defense Formula , on major national cable ... commercials, featuring leading US allergist Dr. Paul H. Ratner, ... of allergies, giving seasonal and year-round sufferers the first ...
... is being released by SafeMinds ( www.SafeMinds.org ): ... publicly denied a vaccine-autism link, while at the same ... awarding damages for vaccine injury to children with brain ... verifiable government data, breaks ground in the controversial vaccine-autism ...
Cached Medicine Technology:Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula 2Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula 383 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court 2
(Date:5/3/2015)... 03, 2015 Looking for a ... directly impact your career? The Master of International ... leaders in multinational companies and for professionals seeking ... changing global landscape, differences in culture, religion, government, ... EMIB program develops the global competence and confidence ...
(Date:5/3/2015)... It is not too late to register to ... Memory of Lissa Anne Been in Arnold, Missouri on May ... event to honor her loving memory. It has benefited the renowned ... having turned 37, Lissa suffered a brain aneurysm . After ... 2012. This event is designed to serve as a remembrance of ...
(Date:5/2/2015)... 2015 Ticket Down has secured additional inventories ... long awaited event today, Saturday, May 2nd at the MGM ... will be able to secure tickets for both the actual ... boxing fans have wanted for more than five years was ... Mayweather will step inside the ring to fight Manny “Pac-Man” ...
(Date:5/2/2015)... ProText Kinetic 2 is a set of typography ... X. ProText Kinetic 2 features 40 animation presets ... X . Easily create interactive text videos without having ... Kinetic 2. , Using ProText Kinetic is as easy as ... presets in the FCPX timeline. Playback the default animation ...
(Date:5/2/2015)... “ Peachtree Audio ” was featured ... which features the latest and coolest technology products available ... reporter for NewsWatch, conducted the review and shared with ... , Music is an important part of people’s lives ... given the royal treatment. Peachtree Audio does just that ...
Breaking Medicine News(10 mins):Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2
... nearly $1 million from the U.S. Department of Housing ... healthy housing. , The funding was made available through ... UIC researchers will evaluate the health and monetary benefits ... into green, affordable, healthy housing. , At a time ...
... Poster Session at American College of Obstetricians and Gynecologists, ... PEAK Surgical, Inc., a medical device company that ... a proprietary technology, released results from a preclinical study ... associated with improved fascia incision healing in an in ...
... ulcer is an illness that affects a considerable number ... to the classic anti-ulcer therapy has revolutionized treatment of ... no complete cure for this disease. It has been ... to various adverse and side effects. Relapses of the ...
... several other institutions worldwide, have pinpointed for the first ... endemic and epidemic mosquito-borne illness that is a rapidly ... The study, published in the May issue of ... the direct and indirect costs of dengue cases in ...
... Innovations, Inc. (NYSE: IMA ), a global leader ... home through the merger of rapid diagnostics and health management, ... and Merrill Lynch 2009 Health Care Conference being held May ... York City. Ron Zwanziger, Chief Executive Officer, and Jon ...
... May 7 Psychemedics Corporation (Nasdaq: PMD ... period ended March 31, 2009. The Company also ... to shareholders of record as of June 5, 2009 ... will be the Company,s 51st consecutive quarterly dividend.The Company,s ...
Cached Medicine News:Health News:UIC receives $1M HUD grant to study green healthy housing 2Health News:PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery 2Health News:PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery 3Health News:PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery 4Health News:PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery 5Health News:A potential anti-ulcer herb medicine: Rocket 'Eruca sativa' 2Health News:Dengue fever costs billions in health care, lost productivity and absenteeism 2Health News:Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009 2Health News:Psychemedics Corporation Announces First Quarter Results 2Health News:Psychemedics Corporation Announces First Quarter Results 3Health News:Psychemedics Corporation Announces First Quarter Results 4Health News:Psychemedics Corporation Announces First Quarter Results 5Health News:Psychemedics Corporation Announces First Quarter Results 6
Provides a combination of concentrated cold / hot and compression for the neck...
Provides extended cold therapy for acute, chronic, or post-surgical applications. Cryotherapy can reduce pain, swelling and speed recovery....
Provides a combination of concentrated cold / hot and compression for the shoulder...
Provides extended cold therapy to the shoulder area for acute, chronic, or post-surgical applications. The DuraKold products can help reduce pain, edema, and speed recovery....
Medicine Products: